World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
29770
World Ranking
11773
National Ranking
640

Overview

Hans Kreipe is affiliated with Hannover Medical School in Germany and has a significant research footprint in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans multiple subfields, including Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Genetics.

The scholar's research topics focus primarily on Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Lesions and Carcinomas, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, and Myeloproliferative Neoplasms: Diagnosis and Treatment.

Hans Kreipe has published extensively in several academic journals. The most frequent publication venues include:

  • Journal of Clinical Oncology (15 publications)
  • Cancer Research (6 publications)
  • Breast Care (5 publications)
  • Modern Pathology (5 publications)
  • Die Pathologie (5 publications)

Their recent notable papers include:

  • Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group, 2020, JNCI Journal of the National Cancer Institute
  • Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study, 2021, Annals of Oncology
  • Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis, 2020, Cell stem cell
  • Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN, 2020, Blood
  • Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors, 2021, Cancers

Hans Kreipe's frequent co-authors are:

  • Matthias Christgen (61 joint publications)
  • Nadia Harbeck (58 joint publications)
  • Oleg Gluz (56 joint publications)
  • Ulrike Nitz (46 joint publications)
  • Rachel Wuerstlein (37 joint publications)

Best Publications

  • Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

    Erik-Oliver Glocker;Daniel Kotlarz;Kaan Boztug;E. Michael Gertz

  • Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer†

    Ulrich Lehmann;B Hasemeier;M Christgen;M Müller

  • HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

    Josef Rüschoff;Manfred Dietel;Gustavo B Baretton;Susanne Arbogast

  • Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.

    Daniel Kotlarz;Daniel Kotlarz;Rita Beier;Dhaarini Murugan;Dhaarini Murugan;Jana Diestelhorst;Jana Diestelhorst

  • A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition

    Hans-Peter Sinn;Hans Kreipe

  • Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade.

    Philipp Müller;Matthias Kreuzaler;Tarik Khan;Daniela S. Thommen;Daniela S. Thommen

  • The phenotype of human STK4 deficiency

    Hengameh Abdollahpour;Giridharan Appaswamy;Daniel Kotlarz;Daniel Kotlarz;Jana Diestelhorst;Jana Diestelhorst

  • West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment

    Oleg Gluz;Ulrike A. Nitz;Matthias Christgen;Ronald E. Kates

  • Incidence of polyomavirus‐nephropathy in renal allografts: influence of modern immunosuppressive drugs

    Michael Mengel;Magali Marwedel;Jörg Radermacher;Gabriele Eden

  • Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.

    Carsten Denkert;Stephan Wienert;Audrey Poterie;Sibylle Loibl

  • Quantitative assessment of promoter hypermethylation during breast cancer development.

    Ulrich Lehmann;Florian Länger;Henning Feist;Sabine Glöckner

  • Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase

    Danny Jonigk;Mariam Al-Omari;Lavinia Maegel;Meike Müller

  • Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome

    Daniel Kotlarz;Natalia Ziętara;Gulbu Uzel;Thomas Weidemann

  • Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study

    Anke Schwarz;Michael Mengel;Wilfried Gwinner;Joerg Radermacher

  • Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells

    Reena Buurman;Engin Gürlevik;Vera Schäffer;Marlies Eilers

  • Early Calcification of Renal Allografts Detected by Protocol Biopsies: Causes and Clinical Implications

    Wilfried Gwinner;Sylvia Suppa;Michael Mengel;Ludwig Hoy

  • Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial.

    Michael Mengel;Reinhard von Wasielewski;Birgitt Wiese;Thomas Rüdiger

  • Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.

    Undraga Schagdarsurengin;Ludwig Wilkens;Doris Steinemann;Peer Flemming

  • Impact of patatin‐like phospholipase‐3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

    Eric Trépo;Pierre Pradat;Pierre Pradat;Andrej Potthoff;Yukihide Momozawa

  • Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.

    Konrad L. Streetz;Frank Tacke;Ludger Leifeld;Torsten Wüstefeld

Frequent Co-Authors

Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Brigitte Schlegelberger
Brigitte Schlegelberger Hannover Medical School
Gudrun Göhring
Gudrun Göhring Hannover Medical School
Michael Mengel
Michael Mengel University of Alberta
Arnold Ganser
Arnold Ganser Hannover Medical School
Michael J. Clemens
Michael J. Clemens University of Sussex
Aristoteles Giagounidis
Aristoteles Giagounidis Heinrich Heine University Düsseldorf
Doris Steinemann
Doris Steinemann Hannover Medical School
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg
Hermann Haller
Hermann Haller Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine isn't just about medical school—there are numerous online options for those who wish to work in healthcare. Whether you’re planning to move into administration, advanced nursing, or mental health, the right online degree can help you achieve your goals.

If you're interested in leadership roles, a bachelors in healthcare administration is an accessible place to start. This degree provides the fundamentals for future hospital managers or clinic supervisors. For an even greater edge, consider a master's in healthcare administration online, which offers more advanced skills and greater earning potential.

Those drawn to advanced nursing may be interested in the shortest pmhnp program, allowing you to quickly become a psychiatric mental health nurse practitioner. For nurses seeking terminal degrees, there are flexible msn to dnp programs online that let you continue working while studying.

These pathways offer flexibility, affordability, and varied career options for those passionate about healthcare—no matter where you’re starting from.

Best Scientists Citing Hans Kreipe

Trending Scientists